Skye Bioscience, Inc. Common Stock (SKYE) — Capital Reinvestment Ratio

Latest as of June 2014: 8.56x

Skye Bioscience, Inc. Common Stock (SKYE) has a Capital Reinvestment Ratio of 8.56x as of June 2014, meaning it reinvests 9% of its operating cash flow ($7.92K) in capital expenditures ($67.83K). See SKYE cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

8.56x

Capex / Operating Cash Flow

Operating Cash Flow

$7.92K

USD

Capital Expenditures

$67.83K

USD

Data as of

Jun 2014

Most recent filing

Annual Capital Reinvestment Ratio for Skye Bioscience, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Skye Bioscience, Inc. Common Stock from None to None. For live market cap and broader valuation context, see how much is Skye Bioscience, Inc. Common Stock worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow